학술논문
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
Document Type
Article
Author
Source
In Annals of Oncology November 2017 28(11):2754-2760
Subject
Language
ISSN
0923-7534